JP Morgan Chase’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.92M Hold
250,000
﹤0.01% 3138
2026
Q1
$5.71M Buy
+250,000
New +$4.53M ﹤0.01% 3206

Other funds holding ACHC

JP Morgan Chase's ACHC Position: Q2 2026 in Review

JP Morgan Chase increased its Acadia Healthcare (ACHC) stake by 46% in Q2 2026, buying an estimated $1.09M and bringing the position to 135,820 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3673.

JP Morgan Chase first reported a position in ACHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $341M in Q2 2017. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • JP Morgan Chase held 135,820 shares of Acadia Healthcare worth $3.87M as of Q2 2026.
  • JP Morgan Chase bought 42,580 Acadia Healthcare shares in Q2 2026, an estimated $1.09M.
  • Acadia Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3673 holding.
  • JP Morgan Chase first reported a position in Acadia Healthcare in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Acadia Healthcare position peaked at $341M in Q2 2017.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.